Navigation Links
Collaboration offers NIH Clinical Center resources to Damon Runyon clinical investigators
Date:12/21/2010

A new pilot partnership between the National Institutes of Health Clinical Center, the National Cancer Institute's Center for Cancer Research, and the Damon Runyon Cancer Research Foundation will offer some of the capabilities and expertise of America's research hospital to an external group of clinical investigators in cancer research. The special talent and resources of the NIH will allow Damon Runyon-funded investigators to undertake studies and collaborations that will advance understanding of the prevention, diagnosis, and treatment of cancer.

Damon Runyon Clinical Investigators (DRCIs) are early career physician-scientists whose focus is on the translation of basic science discoveries into practical therapies. Since 1946, the Damon Runyon Cancer Research Foundation has invested more than $230 million in early career cancer researchers who have the energy, drive, and creativity to become leading innovators in their fields.

"Thanks to the new three-component partnership, these young investigators can apply to use certain equipment, facilities, and patient cohorts at the Clinical Center in research collaborations with NIH clinician-scientists," said John I. Gallin, M.D., Clinical Center director.

An approved research proposal could also provide access to select research materials, services, or products that may not be available or possible at their home institutions such as products from the Pharmacy Department's Pharmaceutical Development Facility through arrangements with the Clinical Center but without a formal research collaboration with a specific institute.

If the pilot proves successful, the NIH and the Clinical Center may pursue similar partnerships with other NIH institutes and centers and external organizations.

"This is a first step toward opening the doors of the Clinical Center to a new band of clinician-scientists, further supporting the NIH mission to enhance health and reduce the burden of disease," said Gallin. The partnership allows DRCIs to partner with an NIH-tenured or tenure-track investigator on a research project. If the NIH research partner is not identified independently, the DRCI can submit a research proposal to the National Cancer Institute and the Clinical Center for assistance in naming a suitable collaborator.

A scientist applying for a Damon Runyon Cancer Research Foundation Clinical Investigator Award could apply with a mentor from the National Cancer Institute or another NIH institute or center. The application would identify the research to be done and the resources used at the Clinical Center.

"We are thrilled to offer these opportunities and resources to the clinical investigators we fund," said Lorraine Egan, executive director of the Damon Runyon Cancer Research Foundation. To facilitate these partnerships, the Clinical Center and the National Cancer Institute's Center for Cancer Research will create an annually updated portfolio of ongoing research and of the research interests of NIH investigators.

In addition to scientific collaborations, this pilot partnership will provide interested DRCIs opportunities to participate in the Clinical Center's clinical research training curriculum. Courses are Introduction to the Principles and Practice of Clinical Research, Principles of Clinical Pharmacology, and Ethical and Regulatory Aspects of Clinical Research. Furthermore, DRCIs are invited to apply to the Clinical Center Sabbatical in Clinical Research Management.


'/>"/>

Contact: Yung S. Lie
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Related medicine news :

1. AIUM spearheads collaboration to develop guidelines for point-of-care ultrasound applications
2. Hutchinson Center and China CDC sign agreement for research and training collaboration
3. Hospital Collaboration May Boost Surgical Patient Safety
4. Mayo collaboration finds source of breast drug side effect
5. Novel nanotechnology collaboration leads to breakthrough in cancer research
6. Pfizer joins open-access medicinal chemistry public-private collaboration
7. Expert Insights on Health Data Sharing, Collaboration, Quality and Meaningful Use Featured in Latest Carefx Position Paper
8. ECOSTASY™ Sustainable Design Destination Launches Collaboration with 2010 International Year of Biodiversity
9. VRMeetings, Inc. Deploys the most Advanced Web-Based Video Conferencing and Document Collaboration Service over the Managed NTT America IT Infrastructure
10. Johns Hopkins School of Medicine enters collaboration with New York Stem Cell Foundation
11. European collaboration seeks to create World Wide Web for robots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being ... Block Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for ... of Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative ...
(Date:2/5/2016)... ... , ... After years as an active staff surgeon and having served as ... Wayne Carman transitioned to chief of the Division of Plastic Surgery at what is ... chief and began a second three-year term in January of 2016. , The original ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know ... having to wait longer to access the treadmills. It’s a predictable trend. After the ... lose weight and get in shape by joining gyms, starting new walking or running ...
(Date:2/5/2016)... Georgia (PRWEB) , ... February 05, 2016 , ... Dr. ... to announce their 2nd Annual No Cost Dental Day to individuals in need. The ... The purpose of this No Cost Dental Day is to provide dental care to ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that should ... event they are experiencing an illness. Migraines are a severe form of a headache ... migraines would not wish the pain on their worst enemy, the feeling can last ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  Aralez Pharmaceuticals Inc. ... of POZEN Inc. ("POZEN") and Tribute Pharmaceuticals Canada Inc. ("Tribute") ... and shareholders of Tribute. The combined company will operate ... company with operations in Canada , ... United States . Under the terms of the ...
(Date:2/5/2016)... February 5, 2016 --> ... report states that the global active pharmaceuticals ingredients (APIs) ... predicted to reach US$185.9 bn by 2020. It is ... 2014 to 2020. The title of the report is ... by Geography, and by Therapeutic Area) - Global Industry ...
(Date:2/5/2016)... Feb. 5, 2016  Henry Schein, Inc. (NASDAQ: HSIC ... and services to office-based dental, animal health and medical ... agreement to acquire a majority ownership interest in Dental ... in Brazil . ... Dental Cremer is the dental distribution business of Cremer ...
Breaking Medicine Technology: